Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine

计划入组 120 人 · 首次发布于 2017 年 2 月 23 日

LH-001 vs Placebo in Healthy Participants

计划入组 56 人 · 首次发布于 2024 年 8 月 9 日

[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001

计划入组 24 人 · 首次发布于 2021 年 8 月 24 日

VES-001

VAS-001

MDR-001

Pelican Therapeutics, Inc.

United States

The State University of New York

United States

Friedrich Schiller University of Jena

Germany

Vetigenics Secures $6M Seed Funding to Advance Pet-Focused Antibody Therapeutics Pipeline

Vetigenics Initiates First Dual Immune Checkpoint Inhibitor Trial in Dogs with Solid Tumors

Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury